ANGRP, also referred to as angiopoietin-2, plays a significant role in the complex signaling processes that govern angiogenesis, the formation of new blood vessels from pre-existing vasculature. The expression of ANGRP is a tightly regulated event within the cellular milieu, often orchestrated in response to environmental cues and internal physiological demands. One of the primary triggers for ANGRP expression is the cellular response to hypoxic conditions. In an intricate interplay of cellular signaling, hypoxia-inducible factors (HIFs) become stabilized when oxygen levels are low. These factors then translocate to the nucleus, where they bind to hypoxia-responsive elements in the promoter regions of target genes, including that of ANGRP, thereby initiating its transcription. It's not merely the lack of oxygen that can prompt an upsurge in ANGRP levels; various chemical compounds are known to either mimic or induce the hypoxic response, leading to a similar outcome.
Among the chemical activators that can upregulate ANGRP expression, stabilizers of HIF-1α, such as certain small molecule inhibitors, are particularly notable. These molecules can artificially maintain HIF-1α in a stabilized state even under normal oxygen conditions, effectively tricking the cell into behaving as though it's in a hypoxic environment and thus promoting the expression of ANGRP. Other compounds, such as heavy metals and certain non-metallic elements, can also induce the expression of ANGRP through mechanisms that involve oxidative stress or the activation of specific signaling pathways related to cellular stress responses. For example, arsenic trioxide is known to generate reactive oxygen species, which can then activate stress response pathways that include the upregulation of various angiogenic factors. Similarly, high glucose conditions can act as a stimulus for ANGRP expression, as cells seek to adapt to the metabolic stress by promoting angiogenesis. Moreover, certain nanoparticles, which are increasingly common in industrial and research applications, can induce a cellular defensive response, possibly leading to the elevated expression of ANGRP as part of the attempt to maintain tissue integrity and homeostasis. It is important to note that while these compounds have the potential to induce ANGRP expression, their interaction with cellular pathways is intricate and subject to the influence of other factors within the cellular environment.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
N-[(4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinyl)carbonyl]glycine-d3 | 808118-40-3 unlabeled | sc-488006 | 10 mg | $12000.00 | ||
N-[(4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinyl)carbonyl]glycine-d3 may escalate ANGRP expression by stabilizing HIF-1α, thereby activating specific transcriptional programs that include the promotion of ANGRP under conditions that mimic a low-oxygen environment. | ||||||
Cobalt(II) chloride | 7646-79-9 | sc-252623 sc-252623A | 5 g 100 g | $64.00 $176.00 | 7 | |
Cobalt(II) chloride can induce a state mimicking hypoxia, leading to the stabilization of HIF-1α and subsequent escalation in ANGRP expression, contributing to the cellular adaptation to oxygen deprivation. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol, as a potent estrogen, can upregulate the expression of ANGRP by engaging with estrogen receptors, which then bind to estrogen response elements on the ANGRP gene promoter, driving its transcription in hormone-responsive tissues. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Thalidomide can elevate TNF-α levels, which, in turn, could stimulate ANGRP expression by activating nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), a transcription factor that promotes the transcription of genes involved in the inflammatory angiogenesis process. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA, by activating protein kinase C (PKC), can upregulate ANGRP expression via the PKC signaling pathway, which is known to play a critical role in the transcriptional control of genes related to cell proliferation and angiogenesis. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone can upregulate ANGRP expression by engaging glucocorticoid receptors, leading to the activation of glucocorticoid response elements within the ANGRP gene promoter, thus driving its transcription in inflammation-related conditions. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can stimulate ANGRP expression by binding to retinoic acid receptors, which then homodimerize or heterodimerize, binding to retinoic acid response elements in the promoter regions of genes, including those involved in cellular differentiation and angiogenesis. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $89.00 $228.00 | ||
Arsenic trioxide can upregulate ANGRP expression through the generation of reactive oxygen species and the activation of stress response pathways, which include the transcriptional activation of genes that encode proteins responsible for cellular defense mechanisms and vascular remodeling. | ||||||